DK0411734T3 - Antigestagene 11beta-aryl-16alfa,17alfa-cyklohexano-østra-4,9-diener - Google Patents

Antigestagene 11beta-aryl-16alfa,17alfa-cyklohexano-østra-4,9-diener

Info

Publication number
DK0411734T3
DK0411734T3 DK90250200.4T DK90250200T DK0411734T3 DK 0411734 T3 DK0411734 T3 DK 0411734T3 DK 90250200 T DK90250200 T DK 90250200T DK 0411734 T3 DK0411734 T3 DK 0411734T3
Authority
DK
Denmark
Prior art keywords
cyclohexano
dienes
aryl
16alpha
11beta
Prior art date
Application number
DK90250200.4T
Other languages
Danish (da)
English (en)
Inventor
Helmut Dr Kasch
Anatoli Kurischko
Kurt Prof Dr Ponsold
Gudrun Bertram
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of DK0411734T3 publication Critical patent/DK0411734T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK90250200.4T 1989-08-04 1990-08-06 Antigestagene 11beta-aryl-16alfa,17alfa-cyklohexano-østra-4,9-diener DK0411734T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DD89331478A DD289541A5 (de) 1989-08-04 1989-08-04 Verfahren zur herstellung von 11beta-aryl-16 alpha, 17 alph-cyclohexanoestra-4,9-dienen

Publications (1)

Publication Number Publication Date
DK0411734T3 true DK0411734T3 (da) 1994-08-29

Family

ID=5611394

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90250200.4T DK0411734T3 (da) 1989-08-04 1990-08-06 Antigestagene 11beta-aryl-16alfa,17alfa-cyklohexano-østra-4,9-diener

Country Status (9)

Country Link
US (1) US5166199A (ja)
EP (1) EP0411734B1 (ja)
JP (1) JP3061856B2 (ja)
AT (1) ATE105298T1 (ja)
DD (1) DD289541A5 (ja)
DE (1) DE59005593D1 (ja)
DK (1) DK0411734T3 (ja)
ES (1) ES2053090T3 (ja)
WO (1) WO1991001993A1 (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2152671T3 (es) * 1996-05-01 2001-02-01 Us Gov Health & Human Serv Derivados de progesterona sustituidos en posicion 21 como nuevos agentes antiprogestacionales.
US6900193B1 (en) * 1996-05-01 2005-05-31 The United States Of America As Represented By The Department Of Health And Human Services Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents
DE19649984A1 (de) * 1996-11-22 1998-05-28 Schering Ag Cycloalkylsteroide, Verfahren zu ihrer Herstellung, diese Cycloalkylsteroide enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
US6483580B1 (en) 1998-03-06 2002-11-19 Kla-Tencor Technologies Corporation Spectroscopic scatterometer system
US20060111577A1 (en) * 2003-02-28 2006-05-25 Kim Hyun K Method for preparing 17 alpha-acetoxy-11beta-(4-n,n-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione, intermediates thereof, and methods for the preparation of such intermediates
US11103514B2 (en) 2010-05-26 2021-08-31 Corcept Therapeutics, Inc. Treatment of muscular dystrophy
US8722940B2 (en) 2012-03-01 2014-05-13 Saudi Basic Industries Corporation High molybdenum mixed metal oxide catalysts for the production of unsaturated aldehydes from olefins
EP3265127B1 (en) 2015-03-02 2024-02-21 Corcept Therapeutics, Inc. Mifepristone and octreotide for use in the treatment of cushing's syndrome in a patient having an adrenocorticotropic hormone (acth)-secreting pancreatic neuroendocrine tumor
ES2906778T3 (es) 2015-03-30 2022-04-20 Corcept Therapeutics Inc Uso de antagonistas del receptor de glucocorticoides en combinación con glucocorticoides para tratar la insuficiencia suprarrenal
JP6768789B2 (ja) 2015-08-13 2020-10-14 コーセプト セラピューティクス， インコーポレイテッド Ａｃｔｈ依存性クッシング症候群を鑑別診断する方法
EP3405101B1 (en) 2016-01-19 2020-12-23 Corcept Therapeutics, Inc. Differential diagnosis of ectopic cushing's syndrome
EP3641780A4 (en) 2017-06-20 2021-02-24 Corcept Therapeutics, Inc. TREATMENT METHODS OF NEURO-EPITHELIAL TUMORS USING SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS
EP4263807A2 (en) 2020-12-18 2023-10-25 Instil Bio (Uk) Limited Processing of tumor infiltrating lymphocytes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2269350B1 (ja) * 1974-04-30 1978-06-30 Inst Orch Khim
DD251142A1 (de) * 1984-11-29 1987-11-04 Akad Wissenschaften Ddr Verfahren zur herstellung von 16 alpha, 17 alpha-cyclohexano-17 beta-acetylgonen-3-onen
DE3708942A1 (de) * 1987-03-18 1988-09-29 Schering Ag 19,11ss-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
DD277684A1 (de) * 1988-12-05 1990-04-11 Adw Ddr Verfahren zur herstellung von 16 alpha, 17 alpha -carbocyclischen estr-4-en-3-onen
DD277685A1 (de) * 1988-12-05 1990-04-11 Adw Ddr Verfahren zur herstellung von 16 alpha, 17 alpha -cyxlohexano-estra- 4,9-dien-3-onen

Also Published As

Publication number Publication date
EP0411734A1 (de) 1991-02-06
US5166199A (en) 1992-11-24
JPH05509289A (ja) 1993-12-22
DE59005593D1 (de) 1994-06-09
JP3061856B2 (ja) 2000-07-10
EP0411734B1 (de) 1994-05-04
WO1991001993A1 (de) 1991-02-21
ATE105298T1 (de) 1994-05-15
DD289541A5 (de) 1991-05-02
ES2053090T3 (es) 1994-07-16

Similar Documents

Publication Publication Date Title
DK0411734T3 (da) Antigestagene 11beta-aryl-16alfa,17alfa-cyklohexano-østra-4,9-diener
BR9105414A (pt) Esteres de acido ouro(i)mercaptocarboxilico,processo para sua preparacao e emprego
DE69215108D1 (de) Phenylalkansäurederivat, seine herstellung und die trennung seiner optischen isomere
NO160778C (no) Analogifremgangsmaate ved fremstilling av nye antifibrinolytisk aktive tranexaminsyreestere.
ATE63124T1 (de) Prodrugverbindungen, verfahren zu deren herstellung und diese enthaltende zubereitungen mit verzoegerter freisetzung.
AR006515A1 (es) Proceso para la preparacion de (s) -4- { [3- [2 (dimetilamino) etil] -1h- indol-5- il] metil} -2-oxazolidinona; intermediarios de uso exclusivo en dicho proceso; procesos para preparar dichos intermediarios y su uso.
DK400781A (da) Fremgangsmaade til fremstilling af 2-(1,4-benzodioxan-2-ylalkyl) imidazoler
ATE25849T1 (de) Tricyclophosphazen-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
FI834800A0 (fi) Foerfarande foer framstaellning av dialkylaminoalkoxibensylalkohol-derivat
ATE16278T1 (de) Hydroxybenzylamino-aryl verbindungen, verfahren zur deren herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen.
ES2053091T3 (es) 16alfa,17beta-metilen-estra-4,9-dien-3-onas sustituidas en 11beta.
JPS54128588A (en) Antidepressive drugs consisting mainly of 2-(1-piperazinyl)- 4-phenylquinoline
ATE19879T1 (de) Furyloxazolylessigsaeure-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
MA21913A1 (fr) Procede de preparation de derives amino-oligohydroxy inhibiteurs de la renine .
SE8207294L (sv) 1,4-tiazankarboxylsyraderivat, deras framstellning och anvendning och kompositioner vari dessa derivat ingar
JPS51136648A (en) Process for preparation of 2-(1-alkenyl)-2-cyclopentenone
ES497823A0 (es) Un procedimiento para la preparacion de derivados de tirosi-na.
EP0402469A4 (en) Catechol compounds, process for their preparation and pharmaceutical preparation containing same
JPS5731643A (en) 4-methyl-3-formylpentene-1-acid alkyl, manufacture, application thereof to 4-methyl-3-formyl-3-pentene-1-acid and novel intermediate product
DE3867610D1 (de) Prostaglandinderivate, verfahren zu ihrer herstellung und deren pharmazeutische zusammensetzungen.
JPS57106633A (en) 1-halogeno-5-hydroxy-6-methylene-2-heptanol, its derivative and their preparation
ES8304532A1 (es) "procedimiento de preparacion de derivados de etanolamina".
DK151332C (da) Analogifremgangsmaade til fremstilling af dibenzoxazonin-, dibenzoxazecin- eller dibenzoxaazacykloundecanderivater eller de tilsvarende thia- eller azaderivater eller farmaceutisk acceptable syreadditionssalte deraf
JPS54145638A (en) Novel derivative of xk-62-2
JPS51146428A (en) Process for preparation of 2-halomethyl crotonic acid phenyl ester